搜索临床试验以:SYR-472
总计1835个结果
-
CytomX Therapeutics完全的肿瘤 | 乳腺癌 | 乳腺肿瘤 | 乳腺肿瘤,三阴性 | 乳腺肿瘤,激素受体阳性/HER2 阴性美国, 西班牙, 大韩民国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人晚期恶性实体瘤 | 难治性恶性实体瘤 | KRAS基因突变 | 转移性恶性实体瘤 | 表皮生长因子受体基因突变 | ERBB2基因扩增 | ERBB2基因突变 | EGFR基因扩增 | ERBB3基因突变 | ERBB4基因突变美国
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
PfizerArvinas Estrogen Receptor, Inc.招聘中
-
Novartis PharmaceuticalsNantCell, Inc.终止
-
Beijing Suncadia Pharmaceuticals Co., Ltd尚未招聘
-
Puma Biotechnology, Inc.完全的
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的
-
Vancouver Coastal HealthNCIC Clinical Trials Group; Vancouver General Hospital Foundation未知
-
NovaBay Pharmaceuticals, Inc.Novum Pharmaceutical Research Services; International Dermatology Research, Inc.完全的
-
Harbin Medical UniversityJiangsu HengRui Medicine Co., Ltd.未知肝细胞癌 | 非小细胞肺癌 | 钢筋混凝土
-
Puma Biotechnology, Inc.完全的
-
SCRI Development Innovations, LLCAchieve Life Sciences完全的
-
Clarity Pharmaceuticals Ltd完全的
-
SCRI Development Innovations, LLCAchieve Life Sciences完全的
-
Bandim Health ProjectUniversity of Southern Denmark完全的
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)终止
-
Shanghai Hengrui Pharmaceutical Co., Ltd.邀请报名